GI Innovation, Inc. (358570.KQ)

KRW 9790.0

(-4.39%)

Operating Expenses Summary of GI Innovation, Inc.

  • GI Innovation, Inc.'s latest annual operating expenses in 2023 was 57.59 Billion KRW , down -18.54% from previous year.
  • GI Innovation, Inc.'s latest quarterly operating expenses in 2024 Q2 was 8.8 Billion KRW , down -27.19% from previous quarter.
  • GI Innovation, Inc. reported a annual operating expenses of 70.69 Billion KRW in annual operating expenses 2022, up 98.23% from previous year.
  • GI Innovation, Inc. reported a annual operating expenses of 35.66 Billion KRW in annual operating expenses 2021, up 8.91% from previous year.
  • GI Innovation, Inc. reported a quarterly operating expenses of 12.08 Billion KRW for 2024 Q1, down -7.07% from previous quarter.
  • GI Innovation, Inc. reported a quarterly operating expenses of 13 Billion KRW for 2023 Q4, up 12.82% from previous quarter.

Annual Operating Expenses Chart of GI Innovation, Inc. (2023 - 2019)

Historical Annual Operating Expenses of GI Innovation, Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 57.59 Billion KRW -18.54%
2022 70.69 Billion KRW 98.23%
2021 35.66 Billion KRW 8.91%
2020 32.74 Billion KRW 76.11%
2019 18.59 Billion KRW 0.0%

Peer Operating Expenses Comparison of GI Innovation, Inc.

Name Operating Expenses Operating Expenses Difference
HLB Co., Ltd. 109.98 Billion KRW 47.636%
iNtRON Biotechnology, Inc. 7.84 Billion KRW -634.059%
BINEX Co., Ltd. 55.67 Billion KRW -3.444%
Bioneer Corporation 204.55 Billion KRW 71.845%
Anterogen.Co.,Ltd. 7.74 Billion KRW -644.078%
MEDIPOST Co., Ltd. 65.31 Billion KRW 11.822%
CrystalGenomics, Inc. 32.36 Billion KRW -77.921%
Helixmith Co., Ltd 37.36 Billion KRW -54.127%
Chabiotech Co.,Ltd. 285.93 Billion KRW 79.858%
Medy-Tox Inc. 110.88 Billion KRW 48.061%
Peptron, Inc. 16.65 Billion KRW -245.768%
Amicogen, Inc. 52.82 Billion KRW -9.029%
Genexine, Inc. 41.62 Billion KRW -38.351%
HLB Therapeutics Co.,Ltd. 16.16 Billion KRW -256.249%
LegoChem Biosciences, Inc. 98.61 Billion KRW 41.601%
ALTEOGEN Inc. 40.93 Billion KRW -40.693%
PharmaResearch Co., Ltd. 89.44 Billion KRW 35.608%
SillaJen, Inc. 5.11 Billion KRW -1026.57%
JETEMA, Co., Ltd. 25.66 Billion KRW -124.409%
OliX Pharmaceuticals,Inc 35.24 Billion KRW -63.386%
Genomictree Inc. 16.26 Billion KRW -254.094%
MedPacto, Inc. 26.91 Billion KRW -113.946%
D&D Pharmatech 32.16 Billion KRW -79.065%
EASY BIO,Inc. 29.67 Billion KRW -94.099%